Galmed Pharmaceuticals Ltd

NASDAQ:GLMD   3:59:59 PM EDT
0.42
0.00 (+0.83%)
Earnings Announcements

Galmed Pharmaceuticals Reports Q2 Loss Per Share Of $0.15

Published: 08/04/2022 13:06 GMT
Galmed Pharmaceuticals Ltd (GLMD) - Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results.
Q2 Loss per Share $0.15.
Q2 Earnings per Share View $-0.24 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.18

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.17

More details on our Analysts Page.